Pathophysiology of visceral pain
Scoring of pain
Pain is a subjective feeling and cannot be measured objectively.
As scoring systems have been developed
* the Biberoglu-Behrman scale scoring dysmenorrhoea, chronic pelvic pain, deep dyspareunea, (and dyschesia) , pelvic nodularity and tenderness
* more elaborate visual analog scales and questionnaires
Endometriosis
Endometriosis is a prime cause of chronic pelvic pain in women. In summary:
Subtle: no pain
Typical: can be a cause of pain but many women do not have pain
Cystic: most women have severe pain but some 10 to 20% are pain free
Deep: most women have very severe pain but some 10% are without pain
Adenomyosis: probably the majority of women is pain free
Pelvic adhaesions
Adhaesions can cause pain, but probably 50% of women with adhaesions do not have pain.
Other causes
Almost any pathology can cause pain e.g.
Gynaecology: bleeding, a persistent copus luteum, myoma, hydrosalpinx, bowels
Radiated pain from the sacro-ileac joint
Treatment and Placebo effect
Since pain is so multifactoreal a careful investigation is mandatory.
Treatment of pain is associated with a high placebo effect: pain gets better for a few months after which pain starts again.
Visit Dr. Koninckx website Gynsurgery.org
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More